LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,607
تعداد دریافت فایل اصل مقاله11,291,417
Dehghani, Mehdi, Jangjoo, Saranaz, Monabati, Ahmad, Masoomi Bandari, Dena, Namdari, Nasrin. (1397). An Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine. سامانه مدیریت نشریات علمی, 43(6), 659-663. doi: 10.30476/ijms.2018.40578
Mehdi Dehghani; Saranaz Jangjoo; Ahmad Monabati; Dena Masoomi Bandari; Nasrin Namdari. "An Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine". سامانه مدیریت نشریات علمی, 43, 6, 1397, 659-663. doi: 10.30476/ijms.2018.40578
Dehghani, Mehdi, Jangjoo, Saranaz, Monabati, Ahmad, Masoomi Bandari, Dena, Namdari, Nasrin. (1397). 'An Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine', سامانه مدیریت نشریات علمی, 43(6), pp. 659-663. doi: 10.30476/ijms.2018.40578
Dehghani, Mehdi, Jangjoo, Saranaz, Monabati, Ahmad, Masoomi Bandari, Dena, Namdari, Nasrin. An Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine. سامانه مدیریت نشریات علمی, 1397; 43(6): 659-663. doi: 10.30476/ijms.2018.40578

An Unusual Case Report: Occurrence of Renal Cell Carcinoma, Basal Cell Carcinoma and Chronic Lymphocytic Leukemia in a Case of Papillary Thyroid Carcinoma Treated with Radioactive Iodine

Iranian Journal of Medical Sciences
مقاله 11، دوره 43، شماره 6، بهمن 2018، صفحه 659-663    اصل مقاله (1.92 M)
نوع مقاله: Case Report(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2018.40578
نویسندگان
Mehdi Dehghani1؛ Saranaz Jangjoo2؛ Ahmad Monabati3؛ Dena Masoomi Bandari2؛ Nasrin Namdari* 4
1Department of Hematology and Medical Oncology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
3Department of Pathology, Hematopathology and Molecular Pathology, Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4Department of Hematology and Medical Oncology, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
The standard therapy for thyroid cancer is total or near total thyroidectomy, followed by the administration of radioactive iodine for remnant ablation or residual disease. Patients with radioiodine therapy are predisposed to second malignant neoplasms in organs such as central nervous system (CNS), breast, prostate, kidney, bone marrow, salivary gland, and digestive tract. Exposure to carcinogen including occupational and therapy related hazard, aging and genetic susceptibility are other causes of second primary cancers. The second primary malignancies are not uncommon and, nowadays, the prevalence of it is mildly increasing due to the increasing survival of cancer patients and advances in early diagnosis and therapeutic modalities. Here, we present a fifty-one-year-old man with papillary thyroid carcinoma (PTC), who developed chronic lymphocytic leukemia (CLL), renal cell carcinoma (RCC), and basal cell carcinoma (BCC) in 15-20 years after radioactive iodine therapy. Second primary tumors are increasing and environmental, genetic susceptibility and increase in survival of cancer patients are the major risk factors.
کلیدواژه‌ها
Second primary cancer؛ Thyroid cancer؛ Renal cell carcinoma؛ Chronic lymphocytic leukemia؛ Basal cell carcinoma
آمار
تعداد مشاهده مقاله: 6,573
تعداد دریافت فایل اصل مقاله: 1,875


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب